The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) ...

Considering taking supplements to treat anthracycline cardiotoxicity? Below is a list of common natural remedies used to treat or reduce the symptoms of anthracycline cardiotoxicity. Follow the ...

Naomi Dempsey, MD, discussed developments in the HER2-positive breast cancer space, including personalized approaches, less ...

Management. Salvage chemotherapy regimens including bortezomib plus steroid, alkylators plus steroid, bortezomib plus anthracycline and radiotherapy, and combined bortezomib, cyclophosphamide ...

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

Adjuvant use of anthracycline–taxane combination therapy is an accepted strategy in the management of high-risk early-stage breast cancer. However, the introduction of this regimen raises the ...

Southwest Research Institute (SwRI) is collaborating with The University of Texas at San Antonio (UTSA) to explore and ...

Chemotherapy is generally administered before hormone therapy in patients with endocrine-responsive breast cancer, but there is a paucity of data to indicate that long-term outcomes are better ...

The US Food and Drug Administration (FDA) has approved a 420 mg dosage strength of Hercessi (trastuzumab-strf), a biosimilar to Herceptin (trastuzumab). Hercessi, a HER2/neu receptor antagonist, is ...

ASX health stocks have fallen this week but Morgans analyst Scott Power is more optimistic after the Fed cut the cash rate by ...

Adaptimmune received FDA approval for Tecelra, with a 39% response rate in synovial sarcoma. See why I rate ADAP stock as a ...

In 2021, the FDA criticised MSD for relying on an early endpoint to seek approval for Keytruda in early-stage TNBC.